Therapeutics and Targets: Experimental Therapeutics– Biologics

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 11-17 of 17 total displayed.

Past content

Reviews
Pathophysiologic Effects of Vascular-Targeting Agents and the Implications for Combination with Conventional Therapies

Michael R. Horsman and Dietmar W. Siemann
Cancer Res. 2006; 66: 11520-11539. [Abstract] [Full text] [PDF]  

Drug Development Series: Review
Discovery and development of anticancer aptamers

Christopher R. Ireson and Lloyd R. Kelland
Mol. Cancer Ther. 2006; 5: 2957-2962. [Abstract] [Full text] [PDF]  

Review
Therapeutic value of glycosaminoglycans in cancer

George W. Yip, Martin Smollich, and Martin Götte
Mol. Cancer Ther. 2006; 5: 2139-2148. [Abstract] [Full text] [PDF]  

Reviews
Is mda-7/IL-24 a "Magic Bullet" for Cancer?

Paul B. Fisher
Cancer Res. 2005; 65: 10128-10138. [Abstract] [Full text] [PDF]  

Imaging, Diagnosis, Prognosis
The Evolution of Antibodies into Versatile Tumor-Targeting Agents

Michael Z. Lin, Michael A. Teitell, and Gary J. Schiller
Clin. Cancer Res. 2005; 11: 129-138. [Abstract] [Full text] [PDF]  

Review
Use of Replicating Oncolytic Adenoviruses in Combination Therapy for Cancer

Roland L. Chu, Dawn E. Post, Fadlo R. Khuri, and Erwin G. Van Meir
Clin. Cancer Res. 2004; 10: 5299-5312. [Abstract] [Full text] [PDF]  

Reviews
EphB2 as a Therapeutic Antibody Drug Target for the Treatment of Colorectal Cancer

Weiguang Mao, Elizabeth Luis, Sarajane Ross, Johnny Silva, Christine Tan, Craig Crowley, Clarissa Chui, Gretchen Franz, Peter Senter, Hartmut Koeppen, and Paul Polakis
Cancer Res. 2004; 64: 781-788. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   Pages: 1 2